The laryngeal mask airway (LMA) was first described in 1983. I It is being increasingly used in the management of difficult airway problems,2 but has not been widely used in tracheal surgery. Apart from its use in fibreoptic bronchoscopY,3-8 there is only one report of its use during laser resection of a carinal tumour. 9 We have used the LMA for tracheal surgery on two occasions: once for laser surgery of a high tracheal tumour and later for the anaesthetic management of tracheal resection in the same patient. We discuss the advantages and limitations of the LMA in tracheal surgery.
CASE REPORT Operation 1
A 54-year-old, 62 kg female presented with complaints of haemoptysis. The chest X-ray was normal. Fibreoptic bronchoscopy revealed a pedunculated tumour measuring 2 cm x 1.5 cm arising from the posterior wall of the trachea about 3 cm below the vocal cords. There was no stridor at rest or on exertion. Heart rate was 88/min and regular, blood pressure 130/80 mmHg and respirations l4/min. The haemogram, ECG and biochemical investigations were within normal limits. Ablation of the tumour with the Nd-YAG laser was planned.
On the morning of operation the patient was premedicated with intramuscular diazepam lO mg. After preoxygenation, general anaesthesia was induced with thiopentone 300 mg IV. The lungs could be easily inflated by facemask and bag. Suxamethonium 100 mg IV was given and a size 4 Intavent LMA introquced. There was no obstruction or gas leak through the LMA when IPPV was given. Fibreoptic bronchoscopy revealed excellent position of the LMA. Anaesthesia was maintained with nitrous oxide, oxygen, halothane and intermittent doses of suxamethonium. IPPV was given manually, adjusting the tension in the reservoir bag to provide leak-free ventilation with adequate chest expansions. Monitoring consisted of pulse oximetry, ECG and noninvasive blood pressure.
The fibreoptic bronchoscope (FB) with the Nd-YAG laser carrier was introduced through the LMA via a bronchoscopy swivel connector. During resection of the tumour, ventilation was unhindered and the Sp02 remained within normal limits. After the tumour had been resected, it was necessary to remove the FB and the LMA and introduce a rigid bronchoscope (RB) to facilitate suction of blood and to remove charred tumour fragments. The procedure lasted 35 minutes. After removal of the RB, an endotracheal tube (ETT) was passed and the patient transferred to the recovery room. Two hours later there was no further bleeding. The trachea was extubated and the patient discharged to the ward.
Operation 2
Two months after the first operation, the patient returned with complaints of haemoptysis and dyspnoea on exertion. Fib~~oPtic bronchoscopy (performed under topical anae~thesia) and CT scan revealed a fleshy tumour arising from the posterior wall of the trachea, 3-4 cm below the vocal cords. Resection of the involved trachea was planned.
The patient was premedicated with intramuscular diazepam lO mg. After induction of general anaesthesia with thiopentone and suxamethonium, a size 4 LMA was introduced (Figure la). Correct placement was confirmed by the absence of gas leak or obstruction during IPPV as well as by fibreoptic bronchoscopy. Anaesthesia was maintained with nitrous oxide, oxygen, halothane and pethidine. Vecuronium was given to 1. V. DIVATIA ET AL. facilitate manual IPPV. The ECG, Sp02, ETC02 and noninvasive blood pressure were monitored.
The trachea was approached through a cervical incision. During dissection of the trachea and localisation of the tumour, brief periods of tracheal obstruction occurred. These were recognised by an increase in airway pressure and ventilation was momentarily interrupted. Despite these periods of apnoea, the Sp02 and ETC02 remained within normal limits. The anterior wall of the trachea was then excised at the level of the fourth tracheal ring. At this stage, an uncut Portex 6 mm ID ETT (28.5 cm long) was passed blindly through the LMA into the trachea. However, the proximal end of the cuff did not enter the distal tracheal segment. This made ventilation difficult and obstructed the surgical field. The ETT was withdrawn into the proximal trachea with the cuff deflated. A 4 mm suction catheter (Rusch) was introduced through the ETT into the distal trachea ( Figure Ib) . Manual jet ventilation was delivered via the suction catheter using a jet injector at a rate of 12-14 breaths/min. A surgical assistant held the catheter to prevent a whiplash effect during jet ventilation. Anaesthesia was thus maintained for 10 minutes. One tracheal ring and 2 cm of the posterior tracheal wall were excised. On completion of the anastomoses, the suction catheter and ETT were removed and IPPV was resumed through the LMA. The Sp02 remained above 97!1fo throughout the period of jet ventilation, while the ETC02 on resumption of IPPV was 40 mmHg. The rest of the procedure was uneventful. Neuromuscular blockade was reversed with neostigmine and atropine. The LMA was removed and the patient sent to the intensive care unit. She made an uneventful recovery.
DISCUSSION
Several elegant anaesthetic techniques have been developed to facilitate tracheal surgery. 10 However, due to the unavailability of high-frequency apparatus and the problems of intrapulmonary haemorrhage during and after cardiopulmonary bypass, 11 anaesthetic techniques using conventional tracheal or bronchial intubation continue to be employed at our institution. The LMA was used to overcome some of the problems posed by tracheal intubation during tracheal surgery. Attempts to secure the airway by placing the ETT distal to the tumour may result in dislodgement of the tumour, bleeding and oedema, worsening tracheal obstruction 11 while increasing the danger of an airway fire with the Nd-YAG laser. An ETT placed proximal to the tumour avoids contact with the tumour but does not reduce the risk of ignition by the laser beam. 12.1l The presence of an ETT restricts bronchoscopic access to subglottic tumours. In addition, with the tumour at a short distance below the vocal cords, the cuff of a proximally placed ETT may lie in the larynx, with a resultant air leak and danger of laryngeal damage. The LMA, by virtue of its placement above the larynx and trachea, eliminated the dangers of direct contact with the tumour. It eliminated the flammable ETT from the field of laser resection and, although made of combustible silicone, minimised the danger of a major airway fire as it is placed above the vocal cords, distant from the site of firing of the laser. 9 The larger cross-sectional area of the LMA results in a lower increase in airway resistance, with and without a FB through it. 9 This is especially important when spontaneous ventilation is maintained during the procedure. These considerations influenced our decision to prefer the LMA to the ETT for airway management during laser resection of the tracheal tumour. Similar considerations applied for airway management during tracheal resection (Operation 2). In addition, we had used the LMA safely and successfully during Operation 1. Hence, we decided to use the LMA for airway management of tracheal resection as well.
The anaesthetic techniques for tracheal resection using endotracheal and bronchial intubation described by Geffin et al. 11 can be modified for use with the LMA (Figures la, 2a,b) . When a Portex 6 mm ETT with a length of 28.5 cm is passed through the LMA, the upper border of the cuff lies 3 cm below the vocal cords. 14 This results in the cuff intruding into the surgical field when the tumour is more than 3 cm below the vocal cords. Therefore ETTs of greater length are essential. The exact length of the ETT required will FIGURE 2b: A long uncut ETT is passed through the LMA during completion of the anterior anastomosis. depend on the distance of the tumour from the vocal cords and the length of trachea resected. To overcome this limitation, the ETT was withdrawn into the proximal segment to serve as a conduit for the suction catheter. Adequate gas exchange could be maintained by jet ventilation, while the small size of the catheter facilitated completion of the anastomosis. This method is analogous to techniques described previously in which jet ventilation was given through a suction catheter passed down an ETT into the distal tracheal stump. 15, 16 As a further refinement of our technique, the FB passed through the LMA may be retained in the trachea just below the vocal cords. This would enable visual diagnosis of tracheal obstruction during surgery and also permit passage of the ETT through the LMA under bronchoscopic guidance. This would be preferable to blind intubation through the LMA,17 which is unreliable, having a success rate varying from 30070 18 to 90%.14 In addition, vocal cord movements can be assessed through the FB to diagnose injury to the recurrent laryngeal nerve,19,20 which is a known complication of tracheal resection. 21 Nd-YAG laser therapy for tracheal lesions has been performed using the FB22 under general anaesthesia with endotracheal intubation. 23 Several authorities now advocate use of the rigid bronchoscope (RB), especially for major obstructing lesions of the trachea and mainstem bronchi. lo , [24] [25] [26] The external cladding of the FB is flammable, while the RB is non-flammable. The RB is superior to the FB in its ability to control haemorrhage, to clear blood, secretions and smoke and to remove tumour debris. The RB serves as an airway through which the lungs can be ventilated as well as a conduit for passage of a FB and the Nd-YAG laser fibre. Resection time is reduced when a RB is used. 27 Nevertheless, the FB can be safely used for laser resection of peripheraF5,27 as well as small central lesions with low-grade obstruction. 25 The LMA can then be used to advantage, as in our patient. In the only other similar report,9 the LMA and FB were used with spontaneous ventilation for two hours during laser resection of an obstructing carinal tumour. Adequate gas exchange was maintained, but rigid bronchoscopy was subsequently required to increase the speed of resection. However, resection time is unlikely to be prolonged during laser therapy of small tumours.
The presence of a significant increase in airway resistance by an obstructing tumour or by lung disease, or inability to obtain an excellent fit of the LMA, should contraindicate its use in tracheal surgery. In the presence of airway obstruction by the tumour, high inflating pressures during controlled ventilation may result in an unacceptable leak. Peak airway pressures exceeding 25 mbar (19 mmHg) may result in opening of the upper oesophageal sphincter. 28 In 2.5%29 to 6%30 of patients the oesophageal opening may be included within the cuff of the LMA, resulting in inflation of the stomach, hypoventilation and regurgitation of gastric contents, especially in the presence of increased airway resistance. It is therefore mandatory to confirm proper placement of the LMA by clinical methods as well as by fibreoptic bronchoscopy before proceeding with the anaesthetic. In the presence of a significant gas leak through the LMA during IPPV, the ability to assist ventilation during spontaneous breathing is lost. Endotracheal intubation should then be preferred. Although the danger of airway fire during Nd-YAG laser therapy is low, 13,2' there is potential for an intratracheal fire to extend all the way to the anaesthesia circuit if unsafe laser equipment or high inspired concentrations of oxygen are used. 13 The silicone LMA could also be ignited in this rare event.
In conclusion, the LMA has advantages when used in general anaesthesia for tracheal surgery, especially with tumours situated just below the vocal cords. It eliminates the risk of tumour dislodgement and bleeding. It reduces the risk of an airway fire when a laser beam is used. During tracheal resection, it serves as a conduit through which ETTs, suction catheters and fibreoptic bronchoscopes can be passed. However, we do not advocate its use when large tumours produce significant airway obstruction or when perfect fit of the LMA cannot be ensured.
